Synaptogenix Inc (SNPX)

[InTheTrenches]

Some are using the 4-letter word "scam" on twitter.

I think we can unequivocally state that, with all the failed trials in Alzheimer's, anyone who thinks Beta-Amyloid as a PRIMARY target are the ones scamming.

This is based on the scientific research related to the Elan drug (2008). Completely clearing amyloid plaques doesn't change the process of Alzheimer's; further, many elderly have amyloid plaques, but no signs of AD.

And, Tau as a primary target has fared just as poorly in clinical trials.

Hopeful that April will bring good news for NTRP and Bryostatin, and for the patients who suffer this horrific disease.